Metropolitan Life Insurance CO Pulse Biosciences, Inc. Transaction History

Metropolitan Life Insurance CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.85 - $12.84 $3,803 - $12,685	988 New	988 $12,000
Q4 2021 Feb 15, 2022	SELL	$14.78 - $24.4 $58,986 - $97,380	-3,991 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$17.25 - $26.63 $68,844 - $106,280	3,991 New	3,991 $86,000
Q3 2021 Mar 30, 2023	SELL	$17.25 - $26.63 $11,264 - $17,389	-653 Reduced 14.06%	3,991 $86,000
Q3 2021 Nov 15, 2021	BUY	$17.25 - $26.63 $68,844 - $106,280	3,991 New	3,991 $86,000
Q2 2021 Aug 16, 2021	SELL	$16.31 - $23.64 $81 - $118	-5 Closed	0 $0
Q1 2021 Jun 26, 2023	BUY	$22.43 - $44.27 $104,164 - $205,589	4,644 New	4,644 $110 Million
Q1 2021 May 14, 2021	SELL	$22.43 - $44.27 $104,052 - $205,368	-4,639 Reduced 99.89%	5 $110,000
Q4 2020 Jun 22, 2023	BUY	$11.66 - $24.5 $54,149 - $113,778	4,644 New	4,644 $110,000
Q4 2020 Mar 30, 2023	BUY	$11.66 - $24.5 $54,149 - $113,778	4,644 New	4,644 $110,000
Q4 2020 Feb 16, 2021	BUY	$11.66 - $24.5 $54,149 - $113,778	4,644 New	4,644 $111,000
Q3 2017 Nov 14, 2017	SELL	$10.26 - $24.97 $69,357 - $168,797	-6,760 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	6,760	6,760 $233,000

5.41M

139K

84.2K

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $742M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.